Xiangyang Chi

5PUBLICATIONS
32CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsCheminformatics and quantitative structure-activity relationshipsInnate immunityHealth policyGlycoconjugates
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 30, 2026
ACE2-fused nanobody targeting a cryptic RBD epitope broadly neutralizes SARS-like viruses.

|Sep 27, 2025
Licoflavone B Suppresses Influenza A Virus by Targeting the Viral RNA-Dependent RNA Polymerase (RdRp).

Pu Fan, Peng Lv, Sen Zhang

|Aug 29, 2025
Bispecific antibody engineered from two non-protective antibodies confers full protection against anthrax toxin through inhibition of PA83 cleavage.

Zhengshan Chen, Guanying Zhang, Jin Han

|Aug 23, 2024
A retrospective survey on the effectiveness of vaccines administered to individuals in China with regard to inactivated COVID-19 vaccines, Ad5-nCoV and/or aerosolized Ad5-nCoV.

Zhe Zhang, Xiang-Yang Chi, Guan-Ying Zhang

|Jun 24, 2020
A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2.

Xiangyang Chi, Renhong Yan, Jun Zhang

Pageof 1

Frequent Collaborators

3 joint publications

Guanying Zhang

2 joint publications

Zhe Zhang

2 joint publications

Jinlong Zhang

2 joint publications

Wei Chen